CD4+ T-cell priming as biomarker to study immune response to preventive vaccines

T-cell priming is a critical event in the initiation of the immune response to vaccination since it deeply influences both the magnitude and the quality of the immune response induced. CD4+ T-cell priming, required for the induction of high-affinity antibodies and immune memory, represents a key tar...

Full description

Bibliographic Details
Main Authors: Annalisa eCiabattini, Elena ePettini, Donata eMedaglini
Format: Article
Language:English
Published: Frontiers Media S.A. 2013-12-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2013.00421/full
_version_ 1818364776457175040
author Annalisa eCiabattini
Elena ePettini
Donata eMedaglini
author_facet Annalisa eCiabattini
Elena ePettini
Donata eMedaglini
author_sort Annalisa eCiabattini
collection DOAJ
description T-cell priming is a critical event in the initiation of the immune response to vaccination since it deeply influences both the magnitude and the quality of the immune response induced. CD4+ T-cell priming, required for the induction of high-affinity antibodies and immune memory, represents a key target for improving and modulating vaccine immunogenicity. A major challenge in the study of in vivo T-cell priming is due to the low frequency of antigen-specific T cells. This review discusses the current knowledge on antigen-specific CD4+ T-cell priming in the context of vaccination, as well as the most advanced tools for the characterization of the in vivo T-cell priming and the opportunities offered by the application of systems biology.
first_indexed 2024-12-13T22:09:45Z
format Article
id doaj.art-5ed87f39630a4477b08dc08bdd1db203
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-13T22:09:45Z
publishDate 2013-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-5ed87f39630a4477b08dc08bdd1db2032022-12-21T23:29:45ZengFrontiers Media S.A.Frontiers in Immunology1664-32242013-12-01410.3389/fimmu.2013.0042169830CD4+ T-cell priming as biomarker to study immune response to preventive vaccinesAnnalisa eCiabattini0Elena ePettini1Donata eMedaglini2University of SienaUniversity of SienaUniversity of SienaT-cell priming is a critical event in the initiation of the immune response to vaccination since it deeply influences both the magnitude and the quality of the immune response induced. CD4+ T-cell priming, required for the induction of high-affinity antibodies and immune memory, represents a key target for improving and modulating vaccine immunogenicity. A major challenge in the study of in vivo T-cell priming is due to the low frequency of antigen-specific T cells. This review discusses the current knowledge on antigen-specific CD4+ T-cell priming in the context of vaccination, as well as the most advanced tools for the characterization of the in vivo T-cell priming and the opportunities offered by the application of systems biology.http://journal.frontiersin.org/Journal/10.3389/fimmu.2013.00421/fullAdoptive TransferVaccinationCD4+ T cellsmucosal immunityT-cell primingMHC class II tetramers
spellingShingle Annalisa eCiabattini
Elena ePettini
Donata eMedaglini
CD4+ T-cell priming as biomarker to study immune response to preventive vaccines
Frontiers in Immunology
Adoptive Transfer
Vaccination
CD4+ T cells
mucosal immunity
T-cell priming
MHC class II tetramers
title CD4+ T-cell priming as biomarker to study immune response to preventive vaccines
title_full CD4+ T-cell priming as biomarker to study immune response to preventive vaccines
title_fullStr CD4+ T-cell priming as biomarker to study immune response to preventive vaccines
title_full_unstemmed CD4+ T-cell priming as biomarker to study immune response to preventive vaccines
title_short CD4+ T-cell priming as biomarker to study immune response to preventive vaccines
title_sort cd4 t cell priming as biomarker to study immune response to preventive vaccines
topic Adoptive Transfer
Vaccination
CD4+ T cells
mucosal immunity
T-cell priming
MHC class II tetramers
url http://journal.frontiersin.org/Journal/10.3389/fimmu.2013.00421/full
work_keys_str_mv AT annalisaeciabattini cd4tcellprimingasbiomarkertostudyimmuneresponsetopreventivevaccines
AT elenaepettini cd4tcellprimingasbiomarkertostudyimmuneresponsetopreventivevaccines
AT donataemedaglini cd4tcellprimingasbiomarkertostudyimmuneresponsetopreventivevaccines